FRANCA, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.152
EU - Europa 3.120
AS - Asia 2.557
SA - Sud America 337
Continente sconosciuto - Info sul continente non disponibili 225
AF - Africa 91
OC - Oceania 19
Totale 11.501
Nazione #
US - Stati Uniti d'America 5.039
SG - Singapore 876
IT - Italia 758
PL - Polonia 669
CN - Cina 553
SE - Svezia 271
DE - Germania 266
VN - Vietnam 257
BR - Brasile 253
HK - Hong Kong 240
UA - Ucraina 191
FI - Finlandia 188
FR - Francia 169
BD - Bangladesh 165
GB - Regno Unito 146
RU - Federazione Russa 101
KR - Corea 95
IN - India 80
TR - Turchia 77
NL - Olanda 73
IE - Irlanda 64
JP - Giappone 53
BG - Bulgaria 47
CA - Canada 42
MX - Messico 38
ES - Italia 33
AR - Argentina 30
BE - Belgio 24
MA - Marocco 21
PK - Pakistan 19
CH - Svizzera 18
AU - Australia 17
IQ - Iraq 17
PT - Portogallo 17
AT - Austria 16
ID - Indonesia 15
TH - Thailandia 15
EG - Egitto 14
SA - Arabia Saudita 14
SN - Senegal 14
CL - Cile 13
TN - Tunisia 13
SI - Slovenia 12
JO - Giordania 10
UZ - Uzbekistan 10
EC - Ecuador 9
PE - Perù 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DK - Danimarca 7
IR - Iran 7
JM - Giamaica 7
PY - Paraguay 7
CO - Colombia 6
GR - Grecia 6
KE - Kenya 6
MY - Malesia 6
PH - Filippine 6
TW - Taiwan 6
VE - Venezuela 6
NO - Norvegia 5
RO - Romania 5
AZ - Azerbaigian 4
PR - Porto Rico 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
UY - Uruguay 3
AL - Albania 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GT - Guatemala 1
Totale 11.260
Città #
Warsaw 610
Ashburn 594
Singapore 518
Woodbridge 397
Fairfield 378
Ann Arbor 370
Chandler 331
San Jose 304
Trieste 240
Hong Kong 234
Houston 234
Wilmington 196
Seattle 173
Jacksonville 172
Cambridge 139
Munich 134
Beijing 127
Council Bluffs 110
Helsinki 110
Princeton 88
Ho Chi Minh City 87
Boardman 85
Seoul 85
Los Angeles 81
Hefei 78
Milan 68
Chicago 64
Hanoi 64
Columbus 59
Santa Clara 59
Dublin 51
New York 50
Lauterbourg 49
Izmir 47
Sofia 47
London 46
Dallas 45
Moscow 45
Zgierz 45
Frankfurt am Main 39
The Dalles 38
Rome 36
São Paulo 36
Buffalo 33
Dearborn 31
Düsseldorf 28
Tokyo 27
Bremen 23
Phoenix 23
Brussels 21
Shanghai 18
Casablanca 17
Falls Church 16
Fano 16
Turku 16
Orem 15
San Diego 15
Atlanta 14
Brooklyn 14
Dakar 14
Genoa 14
Des Moines 13
Guangzhou 13
Mumbai 13
Shannon 13
Verona 13
Chennai 12
Curitiba 12
Redondo Beach 12
Bern 11
Istanbul 11
Venice 11
Washington 11
Denver 10
Fremont 10
Manchester 10
Montreal 10
Nuremberg 10
Redwood City 10
Stockholm 10
Sydney 10
Tashkent 10
Toronto 10
Amsterdam 9
Baghdad 9
Hangzhou 9
Ljubljana 9
Nanjing 9
Philadelphia 9
San Francisco 9
Bengaluru 8
Brasília 8
Chihuahua City 8
Dong Ket 8
Madrid 8
Memphis 8
Nashville 8
Vienna 8
Amman 7
Bangkok 7
Totale 7.504
Nome #
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 517
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 491
Pharmacogenetics of thiopurines 454
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 438
Pharmacogenetics of treatments for inflammatory bowel disease 383
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 342
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 303
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 302
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 294
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 294
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 272
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 271
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 267
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 261
Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. 251
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 243
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 243
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 236
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 235
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 234
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 232
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 227
Human Immunodeficiency Virus (HIV-1) Auxiliary Protein Vif and Cellular APOBEC Deaminases: Their Roles Unveiled? 217
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 209
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 207
Personalized therapies in pediatric inflammatory and autoimmune diseases. 205
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 205
Expression of kidney and liver bilitranslocase in response to acute biliary obstruction. 203
Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association 202
The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1. 198
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 197
Human DEAD-box ATPase DDX3 shows a relaxed nucleoside substrate specificity 188
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 182
Pharmacological evaluation of drug therapies in Aicardi-Goutières syndrome: insights from patient-derived neural stem cells 175
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 175
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 173
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 171
Identification and Functional Characterization of Bilitranslocase in Sea-Bass (Dicentrarchus labrax) Hepatopancreas 171
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism 167
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 162
Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. 161
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 161
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 154
ITPA genetic polymorphism is possibly associated with survival rate in Korean children with acute lymphoblastic leukemia. 151
Biomarkers for gastrointestinal adverse events related to thiopurine therapy 147
Impact of mercaptopurine metabolites on disease outcome in the AIEOP-BFM ALL 2009 protocol for acute lymphoblastic leukemia 143
SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation 139
Pharmacogenetics of glucocorticoid response 125
The Role of Candidate Polymorphisms in Drug Transporter Genes on High-Dose Methotrexate in the Consolidation Phase of the AIEOP-BFM ALL 2009 Protocol 123
Totale 11.501
Categoria #
all - tutte 31.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.905


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022507 0 0 28 31 24 51 46 28 68 61 40 130
2022/20231.008 96 155 62 145 96 160 8 94 108 30 46 8
2023/2024685 34 54 30 46 65 48 114 116 7 28 79 64
2024/20251.767 51 91 114 168 159 174 157 137 231 223 139 123
2025/20263.430 352 132 214 244 299 265 487 102 430 472 236 197
2026/2027386 97 182 107 0 0 0 0 0 0 0 0 0
Totale 11.501